The estimated Net Worth of Colin Mc Cracken is at least $2.17 Milion dollars as of 22 February 2022. Mr. Cracken owns over 6,520 units of Standard BioTools Inc stock worth over $255,408 and over the last 6 years he sold FLDM stock worth over $0. In addition, he makes $1,911,760 as Chief Commercial Officer at Standard BioTools Inc.
Sign up
Mr. McCracken FLDM stock SEC Form 4 insiders trading
Colin has made over 8 trades of the Standard BioTools Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 6,520 units of FLDM stock worth $24,189 on 22 February 2022.
The largest trade he's ever made was exercising 66,520 units of Standard BioTools Inc stock on 20 May 2021 worth over $246,789. On average, Colin trades about 8,896 units every 46 days since 2019. As of 22 February 2022 he still owns at least 68,843 units of Standard BioTools Inc stock.
You can see the complete history of Mr. Cracken stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Colin McCracken biography
Colin McCracken serves as Chief Commercial Officer of the Company. Mr. McCracken held various positions at Thermo Fisher Scientific, a life sciences company, including vice president, sales, chromatography and mass spectrometry, from 2017 to 2019, and vice president and general manager, Middle East, Africa and Eastern Europe from 2015 to 2017. Prior to Thermo Fisher, Mr. McCracken served as vice president and head of European sales at Life Technologies, a life sciences company, from 2009 to 2013, and as vice president and head of European sales at Invitrogen Corporation, a predecessor of Life Technologies, from 2008 to 2009. Prior to Invitrogen, Mr. McCracken served as national sales manager at QiAGEN, a biotechnology company, from 2002 to 2005. Mr. McCracken received an honors degree in electrical and electronic engineering from the University of Strathclyde in Glasgow.
What is the salary of Colin McCracken?
As the Chief Commercial Officer of Standard BioTools Inc, the total compensation of Colin McCracken at Standard BioTools Inc is $1,911,760. There are 1 executives at Standard BioTools Inc getting paid more, with Stephen Linthwaite having the highest compensation of $3,713,060.
How old is Colin McCracken?
Colin McCracken is 47, he's been the Chief Commercial Officer of Standard BioTools Inc since 2019. There are 10 older and 2 younger executives at Standard BioTools Inc. The oldest executive at Standard BioTools Inc is Vikram Jog, 65, who is the Chief Financial Officer.
What's Colin McCracken's mailing address?
Colin's mailing address filed with the SEC is C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO, CA, 94080.
Insiders trading at Standard BioTools Inc
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... oraz Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
What does Standard BioTools Inc do?
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
What does Standard BioTools Inc's logo look like?
Complete history of Mr. Cracken stock trades at Standard BioTools Inc
Standard BioTools Inc executives and stock owners
Standard BioTools Inc executives and other stock owners filed with the SEC include:
-
Stephen Linthwaite,
President, Chief Executive Officer, Director -
Colin McCracken,
Chief Commercial Officer -
Vikram Jog,
Chief Financial Officer -
Bradley Kreger,
Senior Vice President, Global Operations -
Nicholas Khadder,
Senior Vice President, General Counsel, Corporate Secretary -
Colin McCracken,
Chief Commercial Officer -
Vikram Jog,
Chief Financial Officer -
Bradley Allen Kreger,
Sr. VP of Global Operations -
Gerhard Burbach,
Independent Director -
Nicolas Barthelemy,
Independent Director -
Carlos Paya,
Independent Chairman of the Board -
Laura Clague,
Independent Director -
Bill Colston,
Independent Director -
Angela Peters,
Chief HR Officer -
Mark Spearman,
Sr. Director of Corp. Communications -
Peter DeNardo,
Investor Relations -
Andrew Quong,
Chief Science Officer -
Dr. Stephen R. Quake D.phil., Ph.D.,
Co-Founder & Chairman of Advisory Board -
Venture Capital I Lpversant...,
-
Capital Strategies, L.P.Lev...,
-
John A Young,
Director -
Steven Mc Phail,
GM, PRODUCTION GENOMICS -
Mai Chan Yow,
VP, WW Mfg & MD-Singapore -
Samuel D Colella,
Director -
Jennifer Ling Lee,
See Remarks -
Patrick S Jones,
Director -
Gajus Vincent Worthington,
President & CEO -
William Maxwell Smith,
VP, Legal Affairs & GC -
Marc Unger,
See Remarks -
Evan/ Fa Jones,
Director -
Capital Strategies, L.P.Lev...,
-
Capital Strategies, L.P.Lev...,
-
Capital Strategies, L.P.Lev...,
-
Ana K. Stankovic,
Director -
Robert C Jones,
Exec. VP, Research & Dev. -
Raymond J Whitaker,
Director -
Kenneth J Nussbacher,
Director -
Investments Pte Ltd.Biomedi...,
-
Jeremy Loh,
Director -
Partners, L.P.Euclid Sr Bio...,
-
Easterly Partners Llcle Par...,